LPL Financial’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
LPL Financial's RCUS Position: Q3 2026 in Review
LPL Financial reduced its Arcus Biosciences (RCUS) stake by 1.6% in Q3 2026, selling an estimated $10.2K and leaving 22,088 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #5006.
LPL Financial first reported a position in RCUS in Q1 2024 and has held it in 11 quarters since. The position peaked at $692K in Q2 2026. 243 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- LPL Financial held 22,088 shares of Arcus Biosciences worth $571K as of Q3 2026.
- LPL Financial sold 361 Arcus Biosciences shares in Q3 2026, an estimated $10.2K.
- Arcus Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5006 holding.
- LPL Financial first reported a position in Arcus Biosciences in Q1 2024 and has held it in 11 quarters since.
- LPL Financial's Arcus Biosciences position peaked at $692K in Q2 2026.
- 243 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.